Reversible corneal stromal thinning, acute-onset white cataract and angle-closure glaucoma due to erdafitinib, a fibroblast growth factor receptor inhibitor: Report of three cases
G. Bauters, Michel Pâques, Vincent Borderie, Nacim Bouheraoua
Topics & Concepts
MedicineCataractsGlaucomaOphthalmologySurgeryFibroblast Growth Factor ResearchOcular Oncology and TreatmentsBiomedical Research and Pathophysiology